Author

Maroeska Oudshoorn

Observed names: M J Oudshoorn, M. J. Oudshoorn, M. Oudshoorn, M.J. Oudshoorn

Institution: University Medical Center Utrecht

Observed institutions: Netherlands Organisation for Applied Scientific Research, Utrecht University, University Medical Center Utrecht

OpenAlex ID: A5111755536

Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man

2000 · J. J. P. Bogaards, M. Bertrand, et al. · Xenobiotica · 376

Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Mononuclear Blood Cells by the Iron Chelators Deferoxamine, Deferiprone, and Bleomycin

2000 · Niki A. Georgiou, Tjomme van der Bruggen, et al. · The Journal of Infectious Diseases · 105

Anti-HIV effect of iron chelators: different mechanisms involved

2001 · B.S. van Asbeck, N.A. Georgiou, et al. · Journal of Clinical Virology · 60

Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis

2002 · N. A. Georgiou, T. Van Der Bruggen, et al. · European Journal of Clinical Investigation · 38

Species and Strain Differences in the Hepatic Cytochrome P450-Mediated Biotransformation of 1,4-Dichlorobenzene

1997 · A.M. Hissink, M.J. Oudshoorn, et al. · Toxicology and Applied Pharmacology · 33

Glutathione-dependent biotransformation of the alkylating drug thiotepa and transport of its metabolite monoglutathionylthiotepa in human MCF-7 breast cancer cells.

1998 · N H Cnubben, A J Rommens, et al. · PubMed · 29

Canine mammary growth hormone gene transcription initiates at the pituitary-specific start site in the absence of Pit-1

1999 · Irma S Lantinga-van Leeuwen, Maroeska Oudshoorn, et al. · Molecular and Cellular Endocrinology · 23

Combining iron chelators with the nucleoside analog didanosine in anti-HIV therapy

2000 · Niki A Georgiou, Tjomme van der Bruggen, et al. · Transfusion Science · 8

Mechanism of inhibition of the human immunodeficiency virus type 1 by the oxygen radical generating agent bleomycin

2004 · Niki A Georgiou, Tjomme van der Bruggen, et al. · Antiviral Research · 5

The chemotherapeutic agent bleomycin in a two-drug combination with zidovudine, ritonavir or indinavir synergistically inhibits HIV Type-1 replication in peripheral blood lymphocytes

2001 · Niki A Georgiou, Tjomme van der Bruggen, et al. · International Journal of Antimicrobial Agents · 5

Bleomycin has antiviral properties against drug-resistant HIV strains and sensitises virus to currently used antiviral agents

2005 · Niki A. Georgiou, Tjomme van der Bruggen, et al. · International Journal of Antimicrobial Agents · 3

Human cord blood-derived mast cells adhere to extracellular matrix proteins by functional α4β1 (CD49d/CD29), α5β1 (CD49e/CD29), α4β7 integrins and CD44

2002 · Ilaria Puxeddu, Adrian M Piliponsky, et al. · Journal of Allergy and Clinical Immunology

PDF

The effect of deoxynucleosides on cell proliferation of peripheral blood lymphocytes treated with deferoxamine or hydroxyurea

2000 · Tjomme van der Bruggen, Niki A Georgiou, et al. · Transfusion Science

Inhibition of HIV-1 replication by bleomycin via direct viral DNA damage

2000 · NA Georgiou, Tjomme van der Bruggen, et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)

Glutathione-dependent biotransformation of thiotepa and transport of its glutathione conjugate in MCF-cells

1999 · Nicole H.P. Cnubben, A.J. Rommes, et al. · Socio-Environmental Systems Modeling

Works count: 15

Citation count: 685

H-index: 8

I10-index: 7